Raymond James Financial Services Advisors’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $501K | Buy |
26,916
+4,422
| +20% | +$74.6K | ﹤0.01% | 2612 |
|
|
2024
Q2 | $346K | Sell |
22,494
-81
| -0.4% | -$1.16K | ﹤0.01% | 2787 |
|
|
2024
Q1 | $333K | Sell |
22,575
-5,085
| -18% | -$70.4K | ﹤0.01% | 2777 |
|
|
2023
Q4 | $395K | Buy |
27,660
+11,963
| +76% | +$170K | ﹤0.01% | 2559 |
|
|
2023
Q3 | $219K | Sell |
15,697
-4,376
| -22% | -$56K | ﹤0.01% | 2877 |
|
|
2023
Q2 | $236K | Sell |
20,073
-3,875
| -16% | -$44.1K | ﹤0.01% | 2819 |
|
|
2023
Q1 | $275K | Buy |
23,948
+974
| +4% | +$12K | ﹤0.01% | 2703 |
|
|
2022
Q4 | $286K | Sell |
22,974
-110
| -0.5% | -$1.4K | ﹤0.01% | 2627 |
|
|
2022
Q3 | $303K | Buy |
23,084
+838
| +4% | +$12.4K | ﹤0.01% | 2565 |
|
|
2022
Q2 | $311K | Sell |
22,246
-15,159
| -41% | -$203K | ﹤0.01% | 2559 |
|
|
2022
Q1 | $557K | Buy |
37,405
+23,637
| +172% | +$323K | ﹤0.01% | 2320 |
|
|
2021
Q4 | $186K | Sell |
13,768
-12,862
| -48% | -$182K | ﹤0.01% | 3002 |
|
|
2021
Q3 | $392K | Buy |
26,630
+726
| +3% | +$12.3K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $471K | Buy |
25,904
+895
| +4% | +$15.9K | ﹤0.01% | 2409 |
|
|
2021
Q1 | $434K | Sell |
25,009
-1,644
| -6% | -$28.9K | ﹤0.01% | 2385 |
|
|
2020
Q4 | $463K | Sell |
26,653
-2,433
| -8% | -$38.8K | ﹤0.01% | 2188 |
|
|
2020
Q3 | $401K | Buy |
29,086
+596
| +2% | +$8.75K | ﹤0.01% | 2116 |
|
|
2020
Q2 | $411K | Sell |
28,490
-9,043
| -24% | -$119K | ﹤0.01% | 2035 |
|
|
2020
Q1 | $410K | Sell |
37,533
-3,689
| -9% | -$68K | ﹤0.01% | 1668 |
|
|
2019
Q4 | $880K | Sell |
41,222
-40,956
| -50% | -$917K | ﹤0.01% | 1614 |
|
|
2019
Q3 | $1.89M | Sell |
82,178
-9,375
| -10% | -$200K | 0.01% | 1136 |
|
|
2019
Q2 | $1.8M | Buy |
91,553
+1,501
| +2% | +$29.2K | 0.01% | 1165 |
|
|
2019
Q1 | $1.75M | Sell |
90,052
-4,669
| -5% | -$88.5K | 0.01% | 1144 |
|
|
2018
Q4 | $1.56M | Buy |
94,721
+669
| +0.7% | +$13.5K | 0.01% | 1030 |
|
|
2018
Q3 | $2.17M | Sell |
94,052
-1,638
| -2% | -$37.1K | 0.01% | 1023 |
|
|
2018
Q2 | $2.08M | Sell |
95,690
-975
| -1% | -$19K | 0.01% | 1003 |
|
|
2018
Q1 | $1.71M | Sell |
96,665
-15,392
| -14% | -$271K | 0.01% | 1014 |
|
|
2017
Q4 | $2.1M | Sell |
112,057
-11,316
| -9% | -$225K | 0.01% | 899 |
|
|
2017
Q3 | $2.71M | Buy |
123,373
+82,876
| +205% | +$1.87M | 0.02% | 778 |
|
|
2017
Q2 | $976K | Buy |
40,497
+2,264
| +6% | +$57.6K | 0.01% | 1283 |
|
|
2017
Q1 | $1.07M | Sell |
38,233
-1,210
| -3% | -$31.7K | 0.01% | 1141 |
|
|
2016
Q4 | $963K | Sell |
39,443
-7,329
| -16% | -$168K | 0.01% | 1136 |
|
|
2016
Q3 | $1.18M | Sell |
46,772
-4,119
| -8% | -$98.7K | 0.01% | 1011 |
|
|
2016
Q2 | $1.05M | Sell |
50,891
-3,266
| -6% | -$68.1K | 0.01% | 1013 |
|
|
2016
Q1 | $1.09M | Buy |
54,157
+2,377
| +5% | +$45.6K | 0.01% | 856 |
|
|
2015
Q4 | $1.05M | Buy |
51,780
+17,368
| +50% | +$366K | 0.01% | 902 |
|
|
2015
Q3 | $798K | Buy |
34,412
+11,834
| +52% | +$302K | 0.01% | 844 |
|
|
2015
Q2 | $581K | Buy |
+22,578
| New | +$641K | 0.04% | 437 |
|
|
2013
Q3 | – | Sell |
-28,332
| Closed | -$740K | – | 861 |
|
|
2013
Q2 | $740K | Buy |
+28,332
| New | +$818K | 0.02% | 720 |
|
Other funds holding SBRA
Raymond James Financial Services Advisors's SBRA Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its Sabra Healthcare REIT (SBRA) stake by 20% in Q3 2024, buying an estimated $74.6K and bringing the position to 26,916 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.
Raymond James Financial Services Advisors first reported a position in SBRA in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.71M in Q3 2017. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.
- Raymond James Financial Services Advisors held 26,916 shares of Sabra Healthcare REIT worth $501K as of Q3 2024.
- Raymond James Financial Services Advisors bought 4,422 Sabra Healthcare REIT shares in Q3 2024, an estimated $74.6K.
- Sabra Healthcare REIT made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2612 holding.
- Raymond James Financial Services Advisors first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 39 quarters since.
- Raymond James Financial Services Advisors's Sabra Healthcare REIT position peaked at $2.71M in Q3 2017.
- 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.